STOCK TITAN

[6-K] SciSparc Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of August 2025 (Report No. 4)

 

Commission File Number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F     Form 40-F

 

 

 

 

 

 

CONTENTS

 

On August 28, 2025, SciSparc Ltd. (the “Company”) issued: (i) a press release titled “SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel,” a copy of which is furnished herewith as Exhibit 99.1 and is incorporated by reference herein; and (ii) a press release titled “SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc,” a copy of which is furnished herewith as Exhibit 99.2 and is incorporated by reference herein.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099, 333-275305, 333-269839, 333-266047, 333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437, 333-225773 and 333-286791)  filed with the SEC to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 


EXHIBIT INDEX

 

Exhibit No.    
99.1   Press release issued by SciSparc Ltd. titled “SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel.”
99.2   Press release issued by SciSparc Ltd. titled “SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc.”

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
     
Date: August 28, 2025 By: /s/ Oz Adler
  Name:  Oz Adler
  Title: Chief Executive Officer and Chief Financial Officer

 

3

 

Scisparc

NASDAQ:SPRC

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

2.26M
534.58k
0%
1.5%
2.52%
Biotechnology
Healthcare
Link
Israel
Tel Aviv